Celltrion Reveals Data As It Rolls Out Higher-Strength Adalimumab

Presents One-Year Data From Phase III Trial For Yuflyma Rival To Humira

 
• By David Wallace
Spain Europe Map Scratch Off
Spain is one of the initial launch markets for Yuflyma • Source: Alamy

More from Biosimilars

More from Products